Skip to main content
Clinical Trials/NCT03094741
NCT03094741
Completed
N/A

Evaluation of a Mobile Digital Solution for Cancer Care and Research: A Feasibility Study

Saint John's Cancer Institute1 site in 1 country30 target enrollmentApril 1, 2017

Overview

Phase
N/A
Intervention
Not specified
Conditions
Cancer
Sponsor
Saint John's Cancer Institute
Enrollment
30
Locations
1
Primary Endpoint
Feasibility/ Participation Rate
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

The primary purpose of this pilot study is to evaluate the feasibility and acceptability of a Mobile Digital Solution in monitoring and collecting symptom burden data. The proposed study is meant to be the preparatory work for an intervention study to test the effect of Mobile Digital Solutions on improving patient outcomes by prompting early interventions for symptom relief and support of patient and family caregiver quality of life (QOL).

Detailed Description

Demographic information and patient-reported symptoms will be collected from study participants through a mobile health application called CancerLife that they can download (FREE) from their mobile device app store (Android or iOS). Participants will be asked to broadcast their emotional and physical status through a list of symptom list within the app as well as how that symptom is impacting their quality of life and activities of daily living. This data will be collected inside the application and display in easy to understand pie charts. Participants will also have the option to broadcast their entry to their social network. Since the objective of the current feasibility study is to evaluate the feasibility and acceptability of a Mobile Digital Solution in monitoring and collecting symptom burden and QOL data, the investigators will include a standard validated instrument (FACT-G: Functional Assessment of Cancer Therapy - General) as part of this study. Participants will be asked to complete the FACT-G after initial registration and weekly for up to 4 weeks. Participants will receive electronic mail messages with a link to CancerLife weekly as a reminder to access the website.

Registry
clinicaltrials.gov
Start Date
April 1, 2017
End Date
November 5, 2020
Last Updated
5 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Established diagnosis of cancer
  • Karnofsky Index ≥50%
  • Age \> 18 years

Exclusion Criteria

  • Relevant cognitive impairment
  • Insufficient knowledge of English language to complete the survey

Outcomes

Primary Outcomes

Feasibility/ Participation Rate

Time Frame: 4 weeks

number of individuals who participate in the study divided by the number of individuals who opened the link

Secondary Outcomes

  • Open Rate(4 weeks)
  • Rate of missing data(4 weeks)
  • Retention rate(4 weeks)
  • Participant Satisfaction(4 weeks)
  • Refusal rate(4 weeks)

Study Sites (1)

Loading locations...

Similar Trials